Japan, Jan. 16 -- ALNYLAM PHARMACEUTICALS INC has got intellectual property rights for 'FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF.' Other related details are as follows:
Application Number: JP,2023-209185
Category (FI): A61K31/713,A61K47/02,A61K47/44,A61K47/54,A61K48/00,A61K9/08,A61P43/00,111,A61P7/02,A61P7/10,A61P9/00,A61P9/12,C12N1/15,C12N1/19,C12N1/21,C12N15/113@Z,C12N15/63@Z,C12N5/10
Stage: Grant (IP right document published.)
Filing Date: Dec. 12, 2023
Publication Date: March 19, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
